{"id":25350,"date":"2010-07-01T10:43:03","date_gmt":"2010-07-01T10:43:03","guid":{"rendered":"https:\/\/patientbloodmanagement.org\/resources\/el-tiempo-de-protrombina-prolongado-tras-el-tratamiento-con-factor-vii-activado-recombinante-en-pacientes-traumatizados-con-hemorragia-critica-se-asocia-a-resultados-adversos\/"},"modified":"2024-06-06T15:01:46","modified_gmt":"2024-06-06T15:01:46","slug":"el-tiempo-de-protrombina-prolongado-tras-el-tratamiento-con-factor-vii-activado-recombinante-en-pacientes-traumatizados-con-hemorragia-critica-se-asocia-a-resultados-adversos","status":"publish","type":"resources","link":"https:\/\/patientbloodmanagement.org\/es\/resources\/el-tiempo-de-protrombina-prolongado-tras-el-tratamiento-con-factor-vii-activado-recombinante-en-pacientes-traumatizados-con-hemorragia-critica-se-asocia-a-resultados-adversos\/","title":{"rendered":"El tiempo de protrombina prolongado tras el tratamiento con factor VII activado recombinante en pacientes traumatizados con hemorragia cr\u00edtica se asocia a resultados adversos."},"content":{"rendered":"\n<p>McMullin NR, Wade CE, Holcomb JB, Nielsen TG, Rossaint R, Riou B, Rizoli SB, Kluger Y, Choong PI, Warren B, Tortella BJ, Boffard KD; Grupo de estudio de traumatismos NovoSeven. Colaboradores (25) Nicol A, Tracey R, Marx JS, Degiannis E, Goosen J, Plani F, Fingleson LM, Payen JF, Marty J, Krivosic-Horber R, Freysz M, de La Coussaye JE, Duranteau J, Francois B, Smail N, Petit P, van Aken HK, Hempelmann G, Rivkind AI, Shaked G, Michaelson, Yan AY, Hameed SM, Samra GS, Dobb GJ. J Trauma. 2010 Jul;69(1):60-9.<\/p>\n\n<p>Instituto de Investigaci\u00f3n Quir\u00fargica del Ej\u00e9rcito de EE.UU., BAMC-Fort Sam Houston, Texas, EE.UU.<\/p>\n\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20632246\" target=\"_blank\" rel=\"noopener\"><span lang=\"EN-US\">Resumen<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>McMullin NR, Wade CE, Holcomb JB, Nielsen TG, Rossaint R, Riou B, Rizoli SB, Kluger Y, Choong PI, Warren B, Tortella BJ, Boffard KD; Grupo de estudio de traumatismos NovoSeven. Colaboradores (25) Nicol A, Tracey R, Marx JS, Degiannis E, Goosen J, Plani F, Fingleson LM, Payen JF, Marty J, Krivosic-Horber R, Freysz M, de <a href=\"https:\/\/patientbloodmanagement.org\/es\/resources\/el-tiempo-de-protrombina-prolongado-tras-el-tratamiento-con-factor-vii-activado-recombinante-en-pacientes-traumatizados-con-hemorragia-critica-se-asocia-a-resultados-adversos\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","categories":[252],"tags":[],"class_list":["post-25350","resources","type-resources","status-publish","hentry","category-drogas-es"],"acf":[],"_links":{"self":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources\/25350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/media?parent=25350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/categories?post=25350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/tags?post=25350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}